DaVita Offers Health Economics and Outcomes Research
DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney care as well as a multitude of specialty therapeutic populations, is setting new standards for its Health Economics and Outcomes Research services.
The DCR Health Economics and Outcomes Research team designs and executes studies and economic models and translates the results into tools and products for its customers. By understanding client needs and current trends in the marketplace, DCR has supported access and utilization of multibillion-dollar drug franchises.
DCR’s Health Economics and Outcomes Research services include:
· Strategic consulting
· Economic modeling
· Epidemiology and biostatistics
· Prospective study design, execution, and analysis
· Disease management design, execution, and evaluation
· Psychometric development and validation
· Commercial reimbursement and formulary placement
· Policy analytics and legislative briefings
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
